In addition to general limitations if unable to tolerate inhalation of the challenge agent, contraindications include:

- Airflow limitations in FEV1 less than 60% predicted or 1.5 L

- Inability to consistently reproduce quality spirometry

- Recent myocardial infarction within the past three months

- Uncontrolled hypertension

- Known aortic aneurysm

- Recent ophthalmologic surgery

- Patients at risk forÂ intracranial pressure elevation

In younger patients with smaller airway caliber, hypoxemia is a concern. However, testing can safely be performed utilizing pulse oximetry (SaO2) and transcutaneous oxygen pressure. Methacholine is a pregnancy category C drug and it is not known whether it is excreted in breast milk or is associated with fetal abnormalities.